Bhaskar Anand's most recent trade in Reata Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 210 Class A common stock done at an average price of $168.4 . Disclosure was reported to the exchange on Aug. 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 168.42 per share. | 15 Aug 2023 | 210 | 24,495 (0%) | 0% | 168.4 | 35,368 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 169.06 per share. | 15 Aug 2023 | 193 | 24,705 (0%) | 0% | 169.1 | 32,628 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 102.11 per share. | 14 Jun 2023 | 2,343 | 24,898 (0%) | 0% | 102.1 | 239,248 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 1,562 | 23,438 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.32 per share. | 14 Jun 2023 | 1,562 | 27,241 (0%) | 0% | 27.3 | 42,674 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 85.98 per share. | 15 May 2023 | 950 | 25,815 (0%) | 0% | 86.0 | 81,684 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 81.10 per share. | 15 May 2023 | 136 | 25,679 (0%) | 0% | 81.1 | 11,030 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 84.58 per share. | 07 Mar 2023 | 165 | 26,765 (0%) | 0% | 84.6 | 13,956 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 87.47 per share. | 03 Mar 2023 | 820 | 26,930 (0%) | 0% | 87.5 | 71,725 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,000 | 6,000 | - | - | Employee Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,000 | 27,750 (0%) | 0% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 33,500 | 33,500 | - | - | Employee Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,250 | 24,750 (0%) | 0% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Bhaskar Anand | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,500 | 16,500 (0%) | 0% | 0 | Class A common stock |